Navigation Links
Harnessing Novel Techniques to Beat Dreadful Diabetes
Date:8/6/2014

Los Angeles, CA (PRWEB) August 06, 2014

Diabetes is a global health concern, around 382 million world population is affected by it. It is one of the fastest growing health hazard that is posing great economic and medical challenges to the people across the globe. Apart from creating awareness about the causes and consequences of this disease, it is mandatory to popularize the novel therapeutic techniques to extract the best out of the recent healthcare system. Realizing the gravity of the issue, Diabetes -2014 aims to share and promote the exchange of the latest clinical practices and cutting edge research in diabetes & metabolism.

The 5th World Congress on Diabetes & Metabolism will certainly attract huge gathering with the keynote addresses of renowned scholar emeritus like Dr. John Philip, Tarburton National University, USA; Dr. Dharambir Sanghera, University of Oklahoma Health Sciences Center, USA and Dr. Jane McEneny, Queen’s University, UK.

Several other prominent speakers from across the globe like Anil K Mandal, University of Florida, USA; Mark R Rigby, Indiana University, USA; John S.D. Chan, University de Montreal, Canada; Nicolai Doliba, University of Pennsylvania, USA; Mark Gorrell, Centenary Institute of Cancer Medicine & Cell Biology, Australia; Fang Xu Jiang, University of Western Australia, Australia ; Subrata Chakrabarti, Western University, Canada; Ludvigsson Johnny, Linkoping University, Sweden; Lubov Kolesnikova, Russian Federation, Russia; Vineeta Sharma, Adeno Biosciences, USA; Gundu Rao, University of Minnesota, USA; Premanidhi Panda, Dr. Panda, Diabetes Institute, India will also be a part of this International Medical Conference.

Important topics that will be discussed at Diabetese-2014 are; Clinical Diabetes and Diagnostic Approaches, Diabetes Management, Diabetes and its Complications, Endocrinology: Disorders & Treatment, Advanced Technologies for Treatment of Diabetes, Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes, Genetics of Diabetes, Emerging Focus in Diabetes Research and Transplantation for Diabetes.

OMICS International Group 5th World Congress on Diabetes & Metabolism is designed specifically for primary care and diabetes specialty physicians, doctors, podiatrists, pharmacists, physician assistants, nurse practitioners,psychologists and dietitians, certified diabetes educators and other health care professionals who care for patients with diabetes and who manage diabetes related complications.

With a mission of making the scientific information Open Access, Dr. Srinubabu Gedela established OMICS Group International and promulgated more than 400 peer-reviewed journals. So far, OMICS organized more than 300 International conferences. The Group has taken various new initiatives like OMICS Group eBooks, OMICS Scholars Central, Young Researchers Forum, Student Fellowship and Poster Presentation etc. B2B and Scientific Meetings organized by OMICS Group are excellent platforms for network expansion, business development and one to one interaction.Organizations keen in learning more about the OMICS Group Conferences, future collaboration and Scientific Associations with the reputed international events organized each year in almost all the field of scientific study are free to connect us for details.

To see the list of scientific eminence marking their presence in this pragmatic kindly visit the Scientific Program of the event.

For any further inquiries please contact:

Valentina Diaz
Medical Conference
OMICS Group Conferences
5716 Corsa Ave., Suite110
Westlake, Los Angeles
CA 91362-7354, USA
Phone:+1-650-268-9744
Fax:+1-650-618-1414
Toll free: +1-800-216-6499(USA & Canada)
E-mail: diabetes2014(at)omicsgroup(dot)us

Read the full story at http://www.prweb.com/releases/Diabetes2014/OMICS-Group-Conferences/prweb12072458.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Accelerating Drug Development by Harnessing Technology: New Life Science webinar Hosted by Xtalks
2. Triboelectric generator produces electricity by harnessing friction between surfaces
3. New magnetic yeast marks step toward harnessing Natures magnetic capabilities
4. University of Illinois researchers demonstrate novel, tunable nanoantennas
5. Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks
6. Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information
7. Sequenom Announces Issuance Of European Patent For Novel Methods Of Detecting Fetal Aneuploidy
8. Data Highlights BGB324 as a Potential Novel Treatment Option for Drug Resistant Chronic Myeloid Leukemia
9. NKT Therapeutics Identifies Novel anti-iNKT Antibodies for Depleting or Activating iNKT Cells
10. Phase 2a Findings Demonstrate that CSL112, A Novel Apolipoprotein A-I Infusion Therapy, Has a Favorable Safety Profile, is Well Tolerated and Increases Cholesterol Efflux Capacity in Stable Atherothrombotic Patients
11. SignalRX Pharmaceuticals Issued U.S. Patent Covering Novel Kinase Inhibitors For Treating Cancer and Other Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... 28, 2017 , ... RoviSys, a leading independent provider of ... joined the Cisco® Digital Solutions Integrator Program. As a member of this new ... addresses Industrial IT and Business IT in manufacturing environments. , John Cunningham, ...
(Date:2/28/2017)... ... February 28, 2017 , ... LaunchBio, a ... biotechnology companies today announced it named Joan Siefert Rose as CEO. Rose, ... Durham, NC and will begin work immediately. , Rose most recently served as ...
(Date:2/28/2017)... NEW YORK , February 28, 2017 /PRNewswire/ ... by the FDA for avelumab  Prognosis for urothelial ...   EMD Serono, the ... , in the US and Canada , ... Drug Administration (FDA) has accepted for Priority Review EMD Serono,s ...
(Date:2/27/2017)... Calif. , Feb. 27, 2017 ... company focused on the development and commercialization of ... pain, announced today the U.S. Food and Drug ... Application (NDA) under section 505(b)(2) for DSUVIA™ (formerly ... treatment of patients with moderate-to-severe acute pain in ...
Breaking Biology Technology:
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/26/2017)... Feb. 25, 2017  Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring, announces ... Reentry. "Too often, too many offenders ... county jails are trying to tackle this ongoing ... friends and family members. While significant steps are underway, ...
Breaking Biology News(10 mins):